Ikaria, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 12
Rang # Quantité totale PI 126 552
Note d'activité PI 1,1/5.0    3
Rang # Activité PI 336 421
Parent Mallinckrodt Enterprises LLC
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

3 0
0 0
8 0
1
 
Dernier brevet 2024 - Funtionally modified polypeptide...
Premier brevet 2007 - Liquid chalcogenide compositions...
Dernière marque 2005 - IKARIA
Première marque 2005 - IKARIA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Funtionally modified polypeptides and radiobiosynthesis. Provided herein are compositions and me...
2021 Invention Functionally modified polypeptides and radiobiosynthesis. Provided herein are compositions and me...
2011 Invention Compositions, methods and articles concerning pharmaceutical nitric oxide and controlled patient ...
2010 Invention Methods for treating or preventing radiocontrast agent induced kidney injury. Methods for treatin...
2009 Invention Compositions and methods for treating or preventing hypoxic or ischemic injury. A method for trea...
2008 Invention Compositions comprising sulfide alone or in combination with nitric oxide and their use to. The p...
2007 Invention Combinations of nitric oxide and sulfide and methods of use and manufacture thereof. The present ...
Invention Compositions and methods for enhancing survival and reducing injury under ischemic or hypoxic con...
Invention Liquid chalcogenide compositions and methods of manufacturing and using the same. The present in...
Invention Liquid chalcogenide compositions and methods of manufacturing and using the same. The present inv...
2005 P/S Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ...